OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Improving these processes involves adjusting various parameters, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to increase antibody titer while reducing production financia